semaglutide compounding ending ๐จ FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Semaglutide for weight loss |
Description
The regulatory and supply landscape for retatrutide and semaglutide could not be more different right now, and these practical realities will determine which option is available to most people for the foreseeable future

As eligibility expands and more countries adopt these therapies, access and affordability will determine global health outcomes

Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 20202023

This does not guarantee safety, but it provides the theoretical foundation for why researchers suspected these medications might be compatible with breastfeeding long before human studies confirmed it
